Buprenorphine Hydrochloride 00409-2012-32
- Manufacturer
- Hospira, Inc.
- Dosage Form
- Injection, Solution
- Route
- Intramuscular And Intravenous
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- June 14, 2005
- Listing Expires
- December 31, 2026
- Application
- ANDA074137
Active Ingredients
| Ingredient | Strength |
|---|---|
| Buprenorphine Hydrochloride | .3 mg/mL |
Drug Class
Partial Opioid Agonist [EPC]Partial Opioid Agonists [MoA]
Selected Package
00409-2012-32Selected10 CARTRIDGE in 1 CARTON (0409-2012-32) / 1 mL in 1 CARTRIDGE (0409-2012-03)